Last 0.14 MYR
Change Today -0.005 / -3.57%
Volume 1.9M
GENE On Other Exchanges
Symbol
Exchange
Kuala Lumpur
As of 4:57 AM 07/23/14 All times are local (Market data is delayed by at least 15 minutes).

genetec technology bhd (GENE) Snapshot

Open
0.14
Previous Close
0.14
Day High
0.14
Day Low
0.14
52 Week High
02/5/14 - 0.20
52 Week Low
04/17/14 - 0.09
Market Cap
47.5M
Average Volume 10 Days
1.9M
EPS TTM
0.02
Shares Outstanding
351.7M
EX-Date
09/6/11
P/E TM
7.3x
Dividend
--
Dividend Yield
--
Current Stock Chart for GENETEC TECHNOLOGY BHD (GENE)

Related News

No related news articles were found.

genetec technology bhd (GENE) Related Businessweek News

No Related Businessweek News Found

genetec technology bhd (GENE) Details

Genetec Technology Berhad, an investment holding company, operates as a contract manufacturer of automated industrial equipment, systems, and production tools in Malaysia. The company designs and builds customized factory automation equipment and integrated vision inspection systems, including conceptual design, development of prototype, and mass replication of equipment. It provides engineering services in designing, manufacturing, and integrating custom automation solutions to various needs and applications; custom conveyors and solutions for transportation needs; tooling fabrication and sheet metal works; and services related to evaluating, designing, and implementing inspection and handling systems based on machine vision and image processing. The company also fabricates machine parts and toolings for equipment and replications of systems and equipment; and offers fabrication system integration and engineering products and services. It serves various industries, such as hard disk drive, electronics, automotive, hazardous material containment, pharmaceutical and semiconductor, food, consumer, medical devices, nuclear, conveyor and transportation system, and oil and gas industries. The company was incorporated in 1997 and is based in Bandar Baru Bangi, Malaysia.

Founded in 1997

genetec technology bhd (GENE) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

genetec technology bhd (GENE) Key Developments

Genetec Technology Berhad Announces Unaudited Consolidated Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2014

Genetec Technology Berhad announced unaudited consolidated earnings results for the fourth quarter and full year ended March 31, 2014. For the quarter, the company announced revenue of MYR 18,777,000 compared to MYR 14,488,000 for the same period a year ago. Loss from operations was MYR 3,049,000 compared to MYR 17,435,000 for the same period a year ago. Loss before taxation was MYR 3,288,000 compared to MYR 19,176,000 for the same period a year ago. Loss from continuing operations was MYR 3,432,000 compared to MYR 18,960,000 for the same period a year ago. Profit for the financial period was MYR 2,143,000 compared to loss for the financial period of MYR 34,327,000 for the same period a year ago. Profit attributable to equity holders of the parent company was MYR 3,094,000 or 0.88 sen per basic share compared to loss attributable to equity holders of the parent company of MYR 29,823,000 or 8.48 sen per basic share for the same period a year ago. The substantial improvement in the loss before taxation position in this quarter was mainly attributable to the one-off goodwill written-off of MYR 13.3 million for the company’s investment in all of its USA subsidiaries and MYR 1.1 million legal and professional fees and compensation costs incurred in relation to cessation of the company’s USA operation that was incurred in the preceding year's corresponding quarter. For the full year, the company announced revenue of MYR 116,213,000 compared to MYR 123,112,000 for the same period a year ago. Profit from operations was MYR 1,642,000 compared to loss from operations of MYR 5,749,000 for the same period a year ago. Loss before taxation was MYR 830,000 compared to MYR 8,159,000 for the same period a year ago. Loss from continuing operations was MYR 1,238,000 compared to MYR 7,870,000 for the same period a year ago. Profit for the financial period was MYR 4,911,000 compared to loss for the financial period of MYR 32,093,000 for the same period a year ago. Profit attributable to equity holders of the parent company was MYR 7,004,000 or 1.99 sen per basic share compared to loss attributable to equity holders of the parent company of MYR 25,920,000 or 7.37 sen per basic share for the same period a year ago. Net cash generated from operating activities was MYR 15,471,000 compared to MYR 26,285,000 for the same period a year ago. Purchase of property, plant and equipment was MYR 467,000 compared to MYR 8,268,000 for the same period a year ago.

Genetec Technology Berhad Secures New Orders Worth MYR 28.7 Million

Genetec Technology Berhad announced that the Group has secured new orders worth MYR 28.7 million. The secured orders are expected to contribute positively to Genetec’s earnings for the financial year ending 31 March 2015. The secured orders are not expected to have any material effect on the net assets per share of the Company for the financial year ending 31 March 2015. The tenure of the contracts normally range from three to nine months depending on the size of order and scope of work. The contracts are on project basis and they do not foresee any risk pertaining to new secured orders.

Genetec Technology Berhad Reaches Settlement with CCL Manufacturing Solutions

Genetec informed that it has reached a settlement with CCL Manufacturing Solutions Sdn Bhd in respect of CCL’s claims against Genetec under the Writ of Summons and Statement of Claim (bearing Summons No: B52NCC-29-03/2014) whereby Genetec agrees to pay CCL the amount of MYR 310,000.00 as full and final settlement by way of 6 instalments with effect from April 2014 to September 2014. By virtue of the settlement, both parties had on 7 April 2014 executed the Settlement Agreement and accordingly CCL shall forthwith hold the said Civil Suit at the Shah Alam Session Court in abeyance until full settlement of the 6 instalments. In the event the Shah Alam Sessions Court requires CCL to either withdraw or proceed with the said Civil Suit against Genetec, CCL shall proceed to withdraw the said Civil Suit with no order as to costs.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
GENE:MK 0.14 MYR -0.005

GENE Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for GENE.
View Industry Companies
 

Industry Analysis

GENE

Industry Average

Valuation GENE Industry Range
Price/Earnings 59.3x
Price/Sales 0.4x
Price/Book 0.9x
Price/Cash Flow 5.0x
TEV/Sales 0.1x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact GENETEC TECHNOLOGY BHD, please visit www.genetec.net. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.